Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kristine Aasebø
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Frontiers in Oncology
Cancer Research
Oncology
High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort
PLoS ONE
Multidisciplinary
Related publications
BRAF-mutated Metastatic Colorectal Cancer Between Past and Future
British Journal of Cancer
Cancer Research
Oncology
Novel Recurrently Mutated Genes and a Prognostic Mutation Signature in Colorectal Cancer
Gut
Gastroenterology
T Cell-Engaging BiTE Antibodies Specific for EGFR Potently Eliminate KRAS- And BRAF-mutated Colorectal Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Lauric Acid Can Improve the Sensitization of Cetuximab in KRAS/BRAF Mutated Colorectal Cancer Cells by Retrievable microRNA-378 Expression
Oncology Reports
Medicine
Cancer Research
Oncology
Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
PLoS ONE
Multidisciplinary
Expression of the Mutated Transketolase TKTL1, a Molecular Marker in Gastric Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Blastic Plasmacytoid Dendritic Cell Neoplasm-Like Phenotype Identifies a Subgroup of Npm1-Mutated Acute Myeloid Leukemia Patients With Worse Prognosis
American Journal of Hematology
Hematology
RAS and BRAF in Metastatic Colorectal Cancer Management
Journal of Gastrointestinal Oncology
Oncology
Gastroenterology
